Home
Raptor Pharmaceuticals

Raptor Pharmaceuticals Market Share Analysis for May 2026

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

Industry: N/A

Domainraptorpharma.com

Year Founded2005

Employees51 - 200

Annual Revenue$100M - $200M

Raptor Pharmaceuticals

Raptor Pharmaceuticals (including company regionals)

raptorpharma.com

See more website traffic and engagement information

Raptor Pharmaceuticals Revenue up to May 2026 is 100M - 200M

revenue generated by Raptor Pharmaceuticals top domains

Raptor Pharmaceuticals top domains revenue over 3 years

Revenue for Raptor Pharmaceuticals top domains

raptorpharma.com100M - 200M

See more with Sales Intelligence

Total visits to Raptor Pharmaceuticals's top domains

Understand Raptor Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Raptor Pharmaceuticals's top domains

Analyze Raptor Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Raptor Pharmaceuticals's top domains

See how Raptor Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Raptor Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Raptor Pharmaceuticals

These are the website technologies, by industry, used by Raptor Pharmaceuticals top domains

Widget (3)

reCAPTCHA

Social (2)

Instagram

Audio Video Media (1)

Vimeo

Content Management System (1)

WordPress

More Technologies

5

See all

News & Signals from Raptor Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRaptorpharma hired Smith as President and CEO on Jan 1st '14.In 2014, Ms. Smith was appointed President and CEO at Raptor Pharmaceuticals, a public biotechnology company with two commercial medicines for orphan diseases, where she served until its acquisition in 2016 (by Horizon Pharmaceuticals, Inc.).

NewsHorizon Pharma PLC acquired Raptorpharma for $800M on Oct 25th '16.In 2016, Raptor was acquired by Horizon Therapeutics, from which Annovis licensed worldwide rights to the technology Grieg had patented.